Therefore, in various stages of neurodegenerative disorders involving Parkinson’s disease (PD) and AD, dysregulation of BDNF signaling is delayed until the development of advanced neurodegeneration (Faria et al., 2014a, 2014b). This evidence concerns the gene BDNF and Alzheimer disease.